These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 19012356

  • 1. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ.
    J Rheumatol; 2009 Jan; 36(1):174-82. PubMed ID: 19012356
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ, Espinoza LR, Sherrer YR, Liu-Dumaw M, West CR.
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

  • 5. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S.
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [Abstract] [Full Text] [Related]

  • 7. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW, Kivitz AJ, Brown MT, Verburg KM.
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL, Cryer B, Amer F, Hunt B.
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [Abstract] [Full Text] [Related]

  • 10. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1489-98. PubMed ID: 16669964
    [Abstract] [Full Text] [Related]

  • 11. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.
    ADAPT Research GroupJohns Hopkins Bayview and Johns Hopkins School of Medicine, Baltimore, MD 21224, USA., Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M.
    Neurology; 2007 May 22; 68(21):1800-8. PubMed ID: 17460158
    [Abstract] [Full Text] [Related]

  • 12. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
    Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE, PRECISION Investigators.
    Am Heart J; 2009 Apr 22; 157(4):606-12. PubMed ID: 19332185
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar 22; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 14. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE, Dionne RA.
    Pain; 2004 Sep 22; 111(1-2):13-21. PubMed ID: 15327804
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 22; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2004 Jul 22; 50(7):2191-201. PubMed ID: 15248217
    [Abstract] [Full Text] [Related]

  • 17. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC.
    Ann Med; 2011 Dec 22; 43(8):594-605. PubMed ID: 22017620
    [Abstract] [Full Text] [Related]

  • 18. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.
    Arthritis Rheum; 2005 Feb 22; 52(2):554-62. PubMed ID: 15693001
    [Abstract] [Full Text] [Related]

  • 19. Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis.
    Krishnaswami S, Hutmacher MM, Robbins JL, Bello A, West C, Bloom BJ.
    J Clin Pharmacol; 2012 Aug 22; 52(8):1134-49. PubMed ID: 21878579
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
    Petri M, Hufman SL, Waser G, Cui H, Snabes MC, Verburg KM.
    J Rheumatol; 2004 Aug 22; 31(8):1614-20. PubMed ID: 15290743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.